Virtual Medicinal Product (VMP) - Daclizumab 25mg/5ml solution for infusion vials

Navigation

Name Details

Name Start Date End Date
Name Current Name Daclizumab 25mg/5ml solution for infusion vials Start Date 16-01-2009 End Date
Previous Name Previous Name Daclizumab 25mg/5ml solution for injection vials Start Date 10-06-2004 End Date 15-01-2009

Unit Dose & Form Information

DF Indicator
Discrete
UDFS Indicator
5
UDFS UOM
ml
Unit Dose UOM
vial

Summary

Prescribing Status
Valid as a prescribable product
Controlled Drug Category
No Controlled Drug Status
Route
Intravenous
Form
Solution for infusion
Ontology Form/Route
solutioninfusion.intravenous
Non-availability Indicator
Actual Products not Available
Name Basis
rINN - Recommended International Non-proprietary

Codes

ATC Code
L04AC01
BNF Start Date End Date
Current BNF 08020200 Start Date 04-04-2022 End Date
Previous BNF 08020200 Start Date 10-02-2005 End Date 03-03-2009
SNOMED Codes
Code Start Date End Date
36092711000001103 31-10-2018
327235003 15-08-2003 30-10-2018

VMP Ingredients

VMP ingredients table
Name Basis of Strength Description BOSS Strength and UOM (Nmr) Strength and UOM (Dmr)
Daclizumab Based on Ingredient Substance 5 mg 1 ml

Parent Products

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
3 vial